Menu Search
Equities

Corporativo Fragua SAB de CV

CGSBF:PKL

Corporativo Fragua SAB de CV

Actions
  • Price (USD)0.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Dec 30 1899.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Corporativo Fragua SAB de CV is a Mexico-based company primarily engaged in the drug retail sector. The Company operates a network of pharmacies under the SuperFarmacia brand name. The Company focuses on selling medicaments and medical devices. Its products range also includes grocery, exercise machines, perfumes, houseware, flatware, electronics, personal care products, toys and photographic equipment, among others. The Company offers photo printing and restoration, as well as printing custom calendars, cups and photo albums. The Company operates through a number of subsidiaries, such as Farmacia Guadalajara SA de CV, Fotosistemas Especializados SA de CV, Organizacion de Vigilancia Comercial SA de CV and Operadora SFG S de RL de CV.

  • Revenue in MXN (TTM)112.93bn
  • Net income in MXN4.78bn
  • Incorporated1983
  • Employees57.70k
  • Location
    Corporativo Fragua SAB de CVAv. Enrique Diaz de Leon 261 NteColonia Refugio, Sector HidalgoGUADALAJARA 44600MexicoMEX
  • Phone+52 3 336693333
  • Fax+52 3 336693335
  • Websitehttps://www.farmaciasguadalajara.com.mx/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.